Sentences with phrase «for vaccine companies»

This elegant study, published in Integrative Veterinary Care Journal and American Holistic Veterinary Medical Association Journal, should be an incentive for vaccine companies to address this issue, because vaccines are not without risk; veterinarians should push for a broader study to confirm these findings in a larger population.

Not exact matches

• Sanofi (ENXTPA: SAN) will buy Protein Sciences, a Meriden, Conn. - based vaccines biotech company, for an initial amount of $ 650 million, according to Reuters.

And on the flip side, organizations like Gavi, the massive global public - private vaccine partnership, ensure a certain amount of purchases (albeit for a significantly reduced price) as long as companies commit to providing a reliable stream of treatments.

Add one more name to the new slew of pharma companies trying to counteract the public backlash to big drug price increases: France's Sanofi, a $ 126 billion firm known for its flagship diabetes and vaccines units.

Judith Rodin, Rockefeller Foundation, and Sue Desmond - Hellman, The Gates Foundation CEO, discuss the importance of developing partnerships between private and public companies to provide vaccines and health care for the world's poor.

Arafura Resources Ltd has been awarded a $ 3.3 million federal government grant for its NT rare earths - uranium project while biotechnology company Imugene Ltd has secured an $ 880,000 grant to produce and test bird flu vaccines on chickens.

The company also has vaccines in clinical development for cholera (Vaxchora), anthrax, HIV and hepatitis A.

PARIS (Reuters)- French drugmaker and healthcare group Sanofi is to buy privately - held U.S vaccines biotech company Protein Sciences for an initial amount of $ 650 million, as Sanofi steps up its acquisition program after recently missing two large deals.

Novavax, Inc. (NASDAQ: NVAX), a small - cap clinical - stage vaccine company that focuses on therapies for both known and newly emerging diseases, has lost some support from a Wall Street analyst.

If successful, the company's experimental RSV F vaccine could become part of the standard of care for expecting mothers in the United States, and perhaps even abroad.

Horse owners have launched a $ 53 million lawsuit against the pharmaceutical company responsible for developing the Hendra virus vaccine.

This is the same company that was fined earlier this year nearly a million dollars for the vaccine related deaths of 14 babies in Argentina.

Democrats and liberal groups have successfully attacked Heck on social security privatization and a vote in the state Senate against a bill that would have required insurance companies to cover a vaccine for cervical cancer.

No rapid, reliable test for previous dengue infection is available, so the new guidelines mean that the vaccine can't be widely used; that could lead the company to stop making the vaccine.

The company has begun human testing of its mRNA drugs for cardiovascular disease and cancer, and for vaccines against the flu, Zika, and chikungunya viruses.

Danielle Salha says that the ability to publish her vaccine research was a priority for her when she joined the multinational company Aventis Pasteur as a postdoc a year ago.

Vaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vVaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vaccinesvaccines.

Throughout the company's trials the FDA has been on alert for signs that a patient could have a bad reaction as a result of this vaccine - making approach.

In addition, vaccine - makers that use eggs can not begin developing new vaccines that target new virus strains until the U.S. Centers for Disease Control and Prevention (CDC) creates a live - virus reference strain for these companies to work with, a process that could take several weeks.

The vaccine is given in three infusions; each costs $ 31,000, for a total treatment tab of $ 93,000, the company said today.

So he joined GSK Vaccines in 2010, as a molecular biologist in the company's Antigen - Specific Cancer Immunotherapeutic program, which aims to harness the immune system for the development of well - tolerated cancer therapies.

Being a startup valued at more than a billion dollars — an anomaly that venture capitalists dub a unicorn — comes with scrutiny, and many wonder whether Moderna's pipeline, consisting mostly of vaccines for now, will expand to match the company's original vision of mRNA as a broad treatment platform.

«It's not something that will be a panacea for all [cocaine] addicts,» says John Shields, senior vice president of research at Cantab Pharmaceuticals, a British company that recently bought ImmuLogic's vaccine program.

Yet vaccine companies have little incentive to build expensive new factories to make a product that will mostly be used once wild polio is gone — maybe in three years, maybe 10 — and then only for another five years or so.

In order to promote their patented drugs and vaccines against flu, pharmaceutical companies have influenced scientists and official agencies, responsible for public health standards, to alarm governments worldwide.

The company is developing immunotherapies for cancer and prophylactic vaccines against infectious diseases, both based on RNA molecules.

Jury member Penny Heaton, director of vaccine development at the Bill & Melinda Gates Foundation, said CureVac's RNA technology had «the potential for a large and positive impact on public health,» in a statement released by the company on 10 March.

Supari's position all along has been that the evil drug companies will turn these viruses into vaccines, and then charge so much for their products that the poor countries the viruses came from will never be able to afford the life - saving products.

The company uses cells to grow the virus for the vaccine and claims that this «shows significant time saving» over traditional production with eggs.

The countries pledged the monies to create what amounts to an artificial market for the vaccines to provide incentive for pharmaceutical companies to introduce next - generation pneumococcal injections more rapidly, which could then be shipped to impoverished countries.

Unlike other medical treatments for which companies are driven to keep their products safe because of liability threats, their brief says «the Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.vaccine manufacturers to make their vaccines safer.»

Kieny said that for reasons that aren't fully understood, vaccine companies that use eggs to grow vaccine viruses get yields of only 25 % to 50 % of those obtained during the production of seasonal vaccine.

Last week, the World Health organization reported that vaccine companies have obtained yields of the pandemic vaccine that are 50 % to 75 % lower than those for seasonal flu vaccine.

«This is not something companies can just willy nilly get involved with,» Kurilla said and stressed the need for partnerships between private and public organizations to develop antiviral medications and vaccines.

University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria ® PfSPZ - CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

A promising sign, Fu says, is that at least 15 companies are now producing human rabies vaccines for as low as $ 15 per dose through modern techniques.

In his State of the Union address, President Clinton announced a $ 50 million U.S. contribution to GAVI, as well as a tax credit of up to $ 1 billion for companies investing in new vaccines for malaria, AIDS, and TB.

Sanaria's vaccine aims for 90 % protection or even higher, says CEO Stephen Hoffman, a former U.S. Navy researcher who started the company in his kitchen 8 years ago.

In a dissenting opinion, they accused the court of imposing «its own bare policy preferences» to protect vaccine manufacturers and said it was important for companies to be pushed, at times by litigation, to improve on existing vaccines.

«This publication is the first demonstration of the durability of the antibody responses induced by V920 out to 2 years,» the company said in a statement, using its developmental name for the vaccine.

At a meeting in Geneva this week, the WHO asked pharmaceutical companies and governments for more antiviral drugs and ordinary flu vaccine to prevent chicken handlers being infected by human flu at the same time as bird flu.

Negotiations with the U.S. company that holds the license for commercialization of the vaccine — which contains a gene for the Ebola surface protein stitched into a livestock pathogen known as vesicular stomatitis virus (VSV)-- have needlessly delayed the start of the trial, Becker and several other scientists tell Science.

But first the company wants to be sure that there's a market for the vaccine.

Meanwhile, several biotech companies are launching trials combining neoantigen vaccines and checkpoint inhibitors for various cancers, including Neon Therapeutics in Cambridge, which Wu and Hacohen co-founded.

«Molecular Medicine BioServices makes viruses for companies working on vaccines, gene, and cell therapies.

Activists often slam large pharmaceutical companies for failing to develop drugs that are of critical importance to the developing world.Andrew Witty, GlaxoSmithKline's youthful chief executive, gave those critics pause yesterday in a speech to the Council on Foreign Relations in New York City.Witty promised to sell the company's malaria vaccine that is in late - stage clinical trials in Africa for no more than a 5 percent profit.

The army landed $ 20 million for a trial of an AIDS vaccine after heavy lobbying, in part from the company that makes the vaccine.

From that chat has arisen plans for the MSD Wellcome Trust Hilleman Laboratories — named after a vaccine scientist who worked at Merck — a non-profit research institute that it will act like a nimble biotech company with «dynamic decision - making» in the words of Ted Bianco, director of technology transfer at the Wellcome Trust.

The company's pipeline includes seven additional mRNA prophylactic vaccines, all of which address infectious diseases for which there currently are no approved vaccines.

CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.